ANTABIO
LIVE

Serial Number

79249182

Owner

Antabio SAS

Attorney

Gregory J. Chinlund

Filing Date

Jul 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ANTABIO Trademark

Serial Number: 79249182 • Registration: 5917268

ANTABIO is a trademark filed by Antabio SAS on July 20, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Antabio SAS

Biostep,

Entity Type: 16

Trademark Details

Filing Date

July 20, 2018

Registration Date

November 26, 2019

Published for Opposition

September 10, 2019

Goods & Services

Chemical preparations for use in the production of drugs; [ chemical reagents other than for medical or pharmaceutical purposes; bacterial preparations other than for medical purposes; bacteriological preparations other than for medical purposes; ] chemical preparations for scientific purposes other than for medical purposes [ ; cultures of micro-organisms other than for medical purposes; biological tissue cultures other than for medical purposes; diagnostic preparations other than for medical purposes ]

Pharmaceutical preparations for the treatment of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, ] respiratory [ , neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system ] related diseases, infections and disorders; drugs for human use for the treatment of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, ] respiratory [ , neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases, ] infections and disorders; [ chemicals, namely, enzymes for use in pharmaceutical preparations; ] medical or pharmaceutical preparations, particularly for the diagnosis and treatment of life-threatening and drug-resistant bacterial infections; [ hygienic preparations for medicine, namely, disinfectants; ] chemical preparations for medical or pharmaceutical purposes, especially for the diagnosis and treatment of life-threatening and drug-resistant bacterial infections [ ; bacterial preparations for medical or pharmaceutical purposes; bacteriological preparations for medical or pharmaceutical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; preparations of micro-organisms, namely, cultures of microorganisms for medical or pharmaceutical purposes; chemical reagents for medical or pharmaceutical purposes; biomarker reagents for diagnostics for medical purposes; Pharmaceuticals and natural remedies, being medicines for human purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases, infections and disorders ]

Scientific research, development [ and design services ] in the pharmaceutical [ , biological and clinical ] field; [ biological research; chemistry research; bacteriology research; laboratory testing, namely, bacteriological testing; conducting clinical trials for others; ] quality evaluation, analysis and research in the fields of science and technology made by engineers and researchers; technical project studies, namely, technical research in the field of bacterial infections and diseases [ ; scientific information, advisory and consultancy services relating to the aforesaid ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 28, 2026 NA71
REGISTERED-SEC.71 ACCEPTED
Mar 28, 2026 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 23, 2026 APRE
TEAS SECTION 71 RECEIVED
Nov 26, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 26, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 6, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 3, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 17, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 17, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 26, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2019 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 25, 2019 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2019 NONP
ASSIGNED TO LIE
Aug 5, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2019 TROA
REFUSAL PROCESSED BY IB
Feb 16, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 26, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jan 26, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Jan 18, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 16, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 15, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 14, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 10, 2019 REPR